Put "CHEK" on your Radar!

Here's why you should do your due diligence on the following company. There are a number of elevating factors that are worth looking into including proof of spikeability and a low float. Take a Look at "CHEK"  Folks, Get ready for a juicy stock idea!   Check-Cap Ltd is a clinical stage medical diagnostics company that engages in the development of a capsule-based screening technology for CRC detection.   Once the ingestible capsule C-Scan Cap is swallowed, it travels naturally along the gastrointestinal tract while scanning the inner lining of the colon.    C-Scan Cap actively communicates with the second element of the system, C-Scan Track, which records and stores the scanning data.  When the screening procedure is over, C-Scan Cap is excreted naturally, and the scanning data can be analyzed by using Check-Cap's proprietary software, C-Scan View.   Why is this unique approach a big deal? Because current testing methodologies are uncomfortable, resulting in 1 in 3 Americans not getting screened for CRC. The number is similar in Germany and substantially higher in China (according to Check-Cap).   A high percentage wouldn't matter much if the overall number of cases was low, however this isn't the case...   The worldwide numbers for 2020 came in at around 1.9 million!   This means that Check-Cap has a tremendous market opportunity if they are able to play their cards right... In fact, Check-Cap predicts a screening population of 937 million between the United States, Europe, and China. That's a collective market opportunity of $94 billion between these three markets! Even a small chunk of this breakdown would be a game-changer for Check-Cap and it's stock!   Speaking of CHEK... While the fundamental picture is something worth highlighting, the stock's technical setup is arguably the star of the show.   CHEK had two massive rallies over the past two months or so! This demonstrates a strong proof of spikeability and is likely to keep the bulls on their toes while they wait for the next big opportunity to pounce on.   Here's the crazy part...   It wouldn't even take that many bulls to bring CHEK back to its former glory. That's because the stock's float is only 4.38 million according to Finviz! There are no guarantees that this upward potential will turn into reality, but it is something to keep an eye on. Anyways... That's all for now! Until Next Time, -Damian InsiderOwl is a financial newsletter powered by ZipTrader that offers insight into the latest insider trades. This includes CEOs, CFOs, Big Money Institutions, Politicians, and More.   BY READING THIS EMAIL & ALL ZIPTRADER CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZIPTRADER LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk. Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. TRADING IS RISKY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered here if you are not prepared with the reality that most fail. We reserve the right to have affiliate relationships with advertisers/sponsors. Terms of Service & Disclosures Found Here.  Want To Stop Receiving Emails from InsiderOwl?  Unsubscribe ZipTrader LLC 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA